Mirjam Blattner-Johnson

Dr. Mirjam Blattner-Johnson is a scientist at the Hopp Children's Cancer Center Heidelberg (KITZ) and German Cancer Research Center (DKFZ); Science Professor at Rīga Stradiņš University and (RSU) and Children's Clinical University Hospital (BKUS).

Dr Blattner-Johnson completed her higher education in biomedicine and biotechnology in Vienna, Austria and the Humboldt University Berlin, Germany followed by a PhD at Weill Cornell Medicine in New York, USA. Since 2017, Dr Blattner-Johnson has been the lead analyst for next generation sequencing data for the international paediatric precision medicine program INFORM, which is open across 12 European countries. INFORM has the goal to identify tumour specific targeted therapy by performing and analysing lcWGS; WES, RNAseq and high throughput drug screen on fresh tumour material from paediatric patients post relapse.

In addition, her special research focus is on the molecular classification of newly identified and rare paediatric brain tumours using state-of-the-art molecular diagnostic tools such as DNA methylation profiling, single cell sequencing technologies and integrative proteome and transcriptome profiling.